Status:
COMPLETED
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid-Related Disorders
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Buprenorphine is a medication used to treat opioid addiction, but individuals who use this drug are at risk of abusing it. A buprenorphine and naloxone combination may reduce the likelihood of bupreno...
Detailed Description
Opioid withdrawal symptoms are a major contributing factor for why opioid treatment programs often fail. Individuals with severe opioid withdrawal may experience shaking, muscle and bone pain, nausea,...
Eligibility Criteria
Inclusion
- Current opioid abuse
- Not physically dependent on opioids
Exclusion
- Significant medical or psychiatric illness (e.g., insulin-dependent diabetes or schizophrenia)
- Seeking substance abuse treatment (will be assisted with referrals to community-based treatment programs)
- Pregnant
Key Trial Info
Start Date :
January 1 1997
Trial Type :
INTERVENTIONAL
End Date :
March 1 1998
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00158236
Start Date
January 1 1997
End Date
March 1 1998
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University (BPRU) Bayview Campus
Baltimore, Maryland, United States, 21224 6823